Sheng-Chun Hung

557 total citations
63 papers, 384 citations indexed

About

Sheng-Chun Hung is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Sheng-Chun Hung has authored 63 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Sheng-Chun Hung's work include Prostate Cancer Treatment and Research (20 papers), Bladder and Urothelial Cancer Treatments (18 papers) and Prostate Cancer Diagnosis and Treatment (16 papers). Sheng-Chun Hung is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Bladder and Urothelial Cancer Treatments (18 papers) and Prostate Cancer Diagnosis and Treatment (16 papers). Sheng-Chun Hung collaborates with scholars based in Taiwan, Belgium and China. Sheng-Chun Hung's co-authors include Kun‐Yuan Chiu, Jian‐Ri Li, Shian‐Shiang Wang, Yen‐Chuan Ou, Li‐Wen Chang, Chuan-Shu Chen, Chen‐Li Cheng, Shun‐Fa Yang, Chia‐Yen Lin and Cheng‐Kuang Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Sheng-Chun Hung

55 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheng-Chun Hung Taiwan	11	215	120	101	90	78	63	384
Raj P. Pal United Kingdom	10	177 0.8×	147 1.2×	79 0.8×	69 0.8×	129 1.7×	21	420
Hai-Liang Zhang China	14	249 1.2×	187 1.6×	99 1.0×	103 1.1×	90 1.2×	18	451
Najla Aldaoud Jordan	7	261 1.2×	60 0.5×	91 0.9×	55 0.6×	78 1.0×	23	388
Jason W. Anast United States	9	306 1.4×	154 1.3×	113 1.1×	62 0.7×	132 1.7×	12	495
Muhammad Bulbul Lebanon	12	279 1.3×	101 0.8×	212 2.1×	51 0.6×	71 0.9×	52	481
Pridvi Kandagatla United States	9	105 0.5×	109 0.9×	87 0.9×	50 0.6×	178 2.3×	29	423
Akinori Nukui Japan	13	223 1.0×	113 0.9×	116 1.1×	57 0.6×	211 2.7×	50	501
Tomoyuki Shimabukuro Japan	12	127 0.6×	115 1.0×	137 1.4×	84 0.9×	133 1.7×	30	394
Roman Heuer Germany	10	290 1.3×	180 1.5×	62 0.6×	91 1.0×	54 0.7×	25	377
Ja Yoon Ku South Korea	13	139 0.6×	115 1.0×	190 1.9×	69 0.8×	46 0.6×	49	438

Countries citing papers authored by Sheng-Chun Hung

Since Specialization

Citations

This map shows the geographic impact of Sheng-Chun Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng-Chun Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng-Chun Hung more than expected).

Fields of papers citing papers by Sheng-Chun Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng-Chun Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng-Chun Hung. The network helps show where Sheng-Chun Hung may publish in the future.

Co-authorship network of co-authors of Sheng-Chun Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng-Chun Hung. A scholar is included among the top collaborators of Sheng-Chun Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng-Chun Hung. Sheng-Chun Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Li‐Wen, et al.. (2024). Colon Cancer With Bladder Invasion: A Single Center Experience. In Vivo. 38(6). 2990–3001. 1 indexed citations

Chen, Chuan-Shu, et al.. (2024). Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients. PLoS ONE. 19(9). e0309941–e0309941. 1 indexed citations

Hung, Sheng-Chun, et al.. (2024). Predictive value of polygenic risk score for prostate cancer incidence and prognosis in the Han Chinese. Scientific Reports. 14(1). 20453–20453.

Li, Jian‐Ri, et al.. (2024). Comparing Clinical Efficacy of Different Bacillus Calmette-Guérin Strains in Patients With T1 High Grade Bladder Cancer. Anticancer Research. 44(3). 1299–1307. 1 indexed citations

Yang, Chi‐Rei, Yen‐Chuan Ou, Chen‐Li Cheng, et al.. (2023). Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer. Oncology Letters. 26(1). 284–284. 2 indexed citations

Li, Jian‐Ri, et al.. (2023). Prognostic Factors of Extramammary Paget’s Disease: A Retrospective Study at a Medical Center in Taiwan. In Vivo. 37(6). 2786–2791. 1 indexed citations

Li, Jian‐Ri, Shian‐Shiang Wang, Chuan-Shu Chen, et al.. (2023). Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study. PLoS ONE. 18(1). e0279981–e0279981. 8 indexed citations

Li, Jian‐Ri, Kevin Lu, Chen‐Li Cheng, et al.. (2023). First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study. Anticancer Research. 43(3). 1331–1339. 3 indexed citations

Chang, Li‐Wen, Sheng-Chun Hung, Chia‐Yen Lin, et al.. (2023). Nephroscope-assisted single-trocar insertion of peritoneal dialysis catheter prolongs the usage period of catheter compared with laparoscopic technique: Ten-year experience of a single-center. Asian Journal of Surgery. 47(1). 303–309.

10.

Chang, Li‐Wen, Jian‐Ri Li, Cheng‐Kuang Yang, et al.. (2023). Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort Study. Anticancer Research. 43(7). 3193–3201. 3 indexed citations

11.

Lin, Yu‐Ju, Li‐Wen Chang, & Sheng-Chun Hung. (2021). Macro-Ck type 2 syndrome in prostate adenocarcinoma: Case report and review article. Urology Case Reports. 39. 101805–101805.

12.

Li, Jian‐Ri, et al.. (2020). Surgical Drain-Related Intestinal Obstruction After Robot-Assisted Laparoscopic Radical Prostatectomy in Two Cases. Journal of Endourology Case Reports. 6(4). 343–347. 4 indexed citations

13.

Lin, Chia‐Yen, Shian‐Shiang Wang, Cheng‐Kuang Yang, et al.. (2019). Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy. Urologic Oncology Seminars and Original Investigations. 37(11). 814.e9–814.e16. 13 indexed citations

14.

Hung, Sheng-Chun, Shian‐Shiang Wang, Jian‐Ri Li, et al.. (2019). Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Urologic Oncology Seminars and Original Investigations. 37(9). 573.e9–573.e17. 9 indexed citations

15.

Hung, Sheng-Chun, Ying‐Erh Chou, Jian‐Ri Li, et al.. (2019). Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Urologic Oncology Seminars and Original Investigations. 38(2). 41.e1–41.e9. 5 indexed citations

16.

Chen, Chih‐Jung, Pei‐Ni Chen, Shian‐Shiang Wang, et al.. (2019). Impacts of AURKA Genetic Polymorphism on Urothelial Cell Carcinoma Development. Journal of Cancer. 10(6). 1370–1374. 10 indexed citations

17.

Chang, Li‐Wen, Sheng-Chun Hung, Shian‐Shiang Wang, et al.. (2019). Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center Experience. Anticancer Research. 39(7). 3901–3908. 12 indexed citations

18.

Li, Jian‐Ri, Yen‐Chuan Ou, Shian‐Shiang Wang, et al.. (2018). The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma. Anticancer Research. 38(9). 5339–5345. 13 indexed citations

19.

Hung, Sheng-Chun, Kun‐Yuan Chiu, Chen‐Li Cheng, et al.. (2017). Ureteroscopy-Assisted Laparoscopic Segmental Resection of Ureteral Stricture with a Modified Flank Position: Clinical Experience. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(7). 691–695. 2 indexed citations

20.

Lee, Hsiang‐Lin, Hui‐Ling Chiou, Shian‐Shiang Wang, et al.. (2017). WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(4). 160.e15–160.e21. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact